Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Terlipressin MeSH Descriptor Data 2025


MeSH Heading
Terlipressin
Tree Number(s)
D06.472.699.631.692.781.400.675
D12.644.400.900.400.675
D12.644.456.925.480.750
D12.644.548.691.692.781.400.675
D12.776.631.650.937.400.675
Unique ID
D000077585
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077585
Scope Note
An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.
Entry Term(s)
Glipressin
Gly-Gly-Gly-8-Lys-vasopressin
Glycylpressin
Glypressin
N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin
Remestyp
TGLVP
Terlypressin
Triglycyl Lysine Vasopressin
Triglycyl-(8-lysine)vasopressin
Triglycylvasopressin
Vasopressin, tri-Gly-8-Lys-
Pharm Action
Antihypertensive Agents
Vasoconstrictor Agents
Registry Numbers
7Z5X49W53P
0
Related Numbers
14636-12-5
CAS Type 1 Name
N-(N- (N-glycylglycyl)glycyl)-L-lysinevasopressin
Public MeSH Note
2019; TERLIPRESSIN was indexed under LYPRESSIN/analogs & derivatives 1976-2018
History Note
2019 (1976)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/04/09
Terlipressin Preferred
Remestyp Narrower
Triglycyl-(8-lysine)vasopressin Narrower
page delivered in 0.151s